Dual mechanisms for lysophospholipid induction of proliferation of human breast carcinoma cells

Cancer Research

Volumn 59, Issue 18, 1999, Pages 4732-4737

  Goetzl, Edward J ^a   Dolezalova, Hana ^a   Kong, Yvonne ^a   Zeng, Li ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; COMPLEMENT COMPONENT C3; ENDOTHELIAL DIFFERENTIATION GENE ENCODED G PROTEIN COUPLED RECEPTOR; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPID; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PERTUSSIS TOXIN; PROTEIN ANTIBODY; RECEPTOR SUBTYPE; RHO FACTOR; SOMATOMEDIN B; SOMATOMEDIN RECEPTOR; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INACTIVATION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LIPID INTERACTION; REACTION ANALYSIS;

ANIMALS; ANTIBODIES; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CELL DIVISION; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; I-KAPPA B PROTEINS; IMMEDIATE-EARLY PROTEINS; LYSOPHOSPHOLIPIDS; MICE; NUCLEAR PROTEINS; RABBITS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LYSOPHOSPHATIDIC ACID; RECEPTORS, LYSOPHOSPHOLIPID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPHINGOSINE; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0033568655     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Fourcade, O., Simon, M. F., Viode, C., Rugani, N., Leballe, F., Ragab, A., Fournie, B., Sarda, L., and Chap, H. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell, 80: 919-927, 1995.
2. Spiegel, S., and Milstein, S. Sphingolipid metabolites: members of a new class of lipid second messengers. J. Membr. Biol., 146: 225-233, 1995.
3. Durieux, M. E., and Lynch, K. R. Signaling properties of lysophosphatidic acid. Trends Pharmacol. Sci., 14: 249-254, 1993.
4. Moolenaar, W. H., Kranenburg, O., Postma, F. R., and Zondag, G. Lysophosphatidic acid: G protein signaling and cellular responses. Curr. Opin. Cell Biol., 9: 168-173, 1997.
5. Goetzl, E. J., and An, S. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEB J., 12: 1589-1598, 1998.
6. Hecht, J. H., Weiner, J. A., Post, S. R., and Chun, J. Ventricular zone gene-I (vzg-I) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J. Cell Biol., 135: 1071-1083, 1996.
7. An, S., Dickens, M. A., Bleu, T., Hallmark, O. G., and Goetzl, E. J. Molecular cloning of the human Edg-2 protein and its identification as a functional cellular receptor for lysophosphatidic acid. Biochem. Biophys. Res. Commun., 231: 619-622, 1997.
8. An, S., Bleu, T., Huang, W., Hallmark, O. G., Coughlin, S. R., and Goetzl, E. J. Identification of cDNAs encoding two G protein-coupled receptors for lysosphingolipids. FEBS Lett., 417: 279-282, 1997.
9. An, S., Bleu, T., Hallmark, O. G., and Goetzl, E. J. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J. Biol. Chem., 273: 7906-7910, 1998.
10. Lee, M-J., Van Brocklyn, J. R., Thangada, S., Liu, C. H., Hand, A. R., Menzeleev, R., Spiegel, S., and Hla, T. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-I. Science (Washington DC), 279: 1552-1555, 1998.
11. Cuvillier, O., Rosenthal, D. S., Smulson, M. E., and Spiegel, S. Sphingosine 1-phosphate inhibits activation of caspases that cleave poly(ADP-ribose) polymerase and lamins during Fas- and ceramide-mediated apoptosis in Jurkat T lymphocytes. J. Biol. Chem., 273: 2910-2917, 1998.
12. Goetzl, E. J., Kong, Y., and Mei, B. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax. J. Immunol., 162: 2049-2056, 1999.
13. Hill, C. S., and Treisman, R. Differential activation of c-fos promoter elements by serum, lysophosphatidic acid, G proteins and polypeptide growth factors. EMBO J., 14: 5037-5042, 1995.
14. An, S., Bleu, T., Zheng, Y., and Goetzl, E. J. Recombinant human Edg-2 and Edg-4 lysophosphatidic acid receptors mediate intracellular calcium mobilization. Mol. Pharmacol., 54: 881-888, 1998.
15. Goetzl, E. J., Kong, Y., and Kenney, J. S. Lysophospholipid enhancement of human T cell sensitivity to diphtheria toxin by increased expression of heparin-binding epidermal growth factor. Proc. Assoc. Am. Physic., III: 1-11, 1999.
16. Kaltreider, H. B., Ichikawa, S., Byrd, P. K., Ingram, D. A., Kishiyama, J. L., Sreedharan, S. P., Warnock, M. L., Beck, J. M., and Goetzl, E. J. Upregulation of neuropeptides and neuropeptide receptors in a murine model of immune inflammation in lung parenchyma. Am. J. Resp. Cell. Mol. Biol., 16: 133-145, 1996.
17. Crawford, B. A., Martin, J. L., Howe, C. J., Handelsman, D. J., and Baxter, R. C. Comparison of extraction methods for insulin-like growth factor-I in rat serum. J. Endocrinol., 134: 169-176, 1992.
18. DeLeon, D. D., Terry, C., and Nissley, S. P. Direct detection of insulin like growth factor II (IGF-II) by chemiluminescence without interference by IGF binding proteins. Endocrinology, 134: 1960-1963, 1994.
19. Stewart, A. J., Johnson, M. D., May, F. E. B., and Westley, B. R. Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J. Biol. Chem., 265: 21172-21178, 1994.
20. Yee, D. The insulin-like growth factor system as a target in breast cancer. Breast Cancer Res. Treat., 32: 85-95, 1994.
21. Steele-Perkins, G., Turner, J., Edman, J. C., Hari, J., Pierce, S. B., Stover, C., Rutter, W. J., and Roth, R. A. Expression and characterization of a functional human IGF-I receptor. J. Biol. Chem., 263: 11486-11492, 1988.
22. Roth, R. A. Structure of the receptor for IGF-II: the puzzle amplified. Science (Washington DC), 239: 1269-1271, 1988.
23. Daly, R. J., Harris, W. H., Wang, D. Y., and Darbre, P. D. Autocrine production of insulin-like growth factor II using an inducible expression system results in reduced estrogen sensitivity of MCF-7 human breast cancer cells. Cell Growth Differ., 2: 457-464, 1991.
24. Arteaga, C. L., and Osborne, C. K. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. Cancer Res., 49: 6237-6241, 1989.
25. Xu, Y., Gaudette, D. C., Boynton, J., and Mills, G. B. Characterization of an ovarian cancer activating factor (OCAF) in ascites from ovarian cancer patients. Clin. Cancer Res., I: 1223-1232, 1995.
26. Xu, Y., Shen, Z., Wiper, D. W., Wu, M., Morton, R. E., Elson, P., Kennedy, A. W., Belinson, J., Markman, M., and Casey, G. Lysophosphatidic acid as a potential biomarker in ovarian and other gynecological cancers. J. Am. Med. Assoc., 280: 719-723, 1998.